Phase 4 Ureteral Stones Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Efficacy of Highly Selective-a-1A-Adrenoceptor Antagonist Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled Study
radiopaque lower ureteral stones >5mm
Chung Jing Wang45 enrolled1 locationACTRN12611000571976
Completed
Phase 4
Efficacy of Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled trial
lower ureteral stones
Chung Jing Wang55 enrolled1 locationACTRN12611000555954
Completed
Phase 4
Comparison of 2 lithotripter regarding efficacy / complication rate of kidney and ureteral stones
Comparison of clinical effectiveness and complication rate of the two above mentioned lithotripter. Study population: Patients with kidney and/or ureteral stones.
Department of Urology800 enrolled1 locationACTRN12610000434099